News Releases

Date	Title	Additional Formats
December 2, 2019	Phathom Pharmaceuticals Announces Initiation of Pivotal Phase 3 Clinical Trial for Vonoprazan in Erosive Esophagitis
December 2, 2019	Phathom Pharmaceuticals Expands Leadership Team and Announces Board Transition
November 26, 2019	Phathom Pharmaceuticals to Present at Evercore ISI 2019 HealthCONx Conference
November 25, 2019	Phathom Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 13, 2019	Phathom Pharmaceuticals to Present at Jefferies 2019 London Healthcare Conference
October 29, 2019	Phathom Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 24, 2019	Phathom Pharmaceuticals Announces Pricing of Initial Public Offering
September 27, 2019	Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments
June 4, 2019	Phathom Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
May 15, 2019	Takeda and Frazier Healthcare Partners Announce Collaboration to Launch Phathom Pharmaceuticals